Utilization and cost of serologic tests for Lyme disease in Maryland

被引:11
作者
Strickland, GT
Karp, AC
Mathews, A
Pena, CA
机构
[1] Dept. of Epidemiol. and Prev. Med., University of Maryland, School of Medicine, Baltimore
[2] Dept. of Epidemiol. and Prev. Med., University of Maryland, School of Medicine, Baltimore
关键词
D O I
10.1086/517311
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To ascertain use of serologic tests for Lyme disease (LD) in Maryland, all laboratories registered with the State Health Department were surveyed. Results show that from 1992 to 1995, 17 laboratories performed 100,000 serologic tests costing $7.1 million on Maryland residents; 90% of these tests were EIAs. The proportion of positive EIAs increased from 3.4% in 1992 to similar to 7.0% in 1994 and 1995, and the percentage of positive second tests (Western blot, WB) fell from 7.9% to 5.0%-5.5%. The large number of EIAs performed in comparison with the low incidence of LD in the state results in a low predictive value of a positive EIA test. Therefore, the WE is Indicated to confirm equivocal and positive EIA tests when characteristic clinical findings of LD are not present. The 30,000 tests for LD performed annually on Maryland residents at a cost of over $2 million in direct medical costs must be added to the public health burden of LD in this state.
引用
收藏
页码:819 / 821
页数:3
相关论文
共 8 条
[1]  
Centers for Disease Control and Prevention, 1995, MORB MORTAL WKLY RE, V44, P590
[2]  
Centers for Disease Control and Prevention, 1996, MMWR-MORBID MORTAL W, V45, P481
[3]   The public health impact of Lyme disease in Maryland [J].
Coyle, BS ;
Strickland, GT ;
Liang, YY ;
Pena, C ;
McCarter, R ;
Israel, E .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (05) :1260-1262
[4]   Improved serodiagnostic testing for lyme disease: Results of a multicenter serologic evaluation [J].
Craven, RB ;
Quan, TJ ;
Bailey, RE ;
Dattwyler, R ;
Ryan, RW ;
Sigal, LH ;
Steere, AC ;
Sullivan, B ;
Johnson, BJB ;
Dennis, DT ;
Gubler, DJ .
EMERGING INFECTIOUS DISEASES, 1996, 2 (02) :136-140
[5]   Serodiagnosis of lyme disease: Accuracy of a two-step approach using a flagella-based ELISA and immunoblotting [J].
Johnson, BJB ;
Robbins, KE ;
Bailey, RE ;
Cao, BL ;
Sviat, SL ;
Craven, RB ;
Mayer, LW ;
Dennis, DT .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (02) :346-353
[6]   THE USE OF SEROLOGIC TESTS FOR LYME-DISEASE IN A PREPAID HEALTH PLAN IN CALIFORNIA [J].
LEY, C ;
LE, C ;
OLSHEN, EM ;
REINGOLD, AL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (06) :460-463
[7]   ERYTHEMA MIGRANS AND EARLY LYME-DISEASE [J].
NADELMAN, RB ;
WORMSER, GP .
AMERICAN JOURNAL OF MEDICINE, 1995, 98 :S15-S24
[8]   MUSCULOSKELETAL MANIFESTATIONS OF LYME-DISEASE [J].
STEERE, AC .
AMERICAN JOURNAL OF MEDICINE, 1995, 98 :S44-S51